The Disease of Air Conditioning
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The subject must meet all of the following criteria at the same time: (1) Male or female between 18 and 70 years old; (2) The experience of being exposed to an air-conditioned environment or frequently entering and leaving air-conditioned rooms on hot days (June to October) and at least 3 days before the onset; (3) Meet the diagnostic criteria of Western medicine for the common cold (edited by Chen Haozhu. Practical Internal Medicine. 10th edition. People's Medical Publishing House); (4) Comply with the diagnostic criteria of TCM syndromes for wind-cold cold [Guidelines for TCM Diagnosis and Treatment of Common Colds (2015 Edition)]; (5) Within 48 hours of onset; (6) Those who have not taken Jingfang Granules, Xinkangtai Ke (blue), Tylenol cold tablets, Xinkang Taike (red), Day and Night Baifuzhu (night tablets), etc. within 2 weeks before enrollment; (7) Subjects voluntarily joined the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: Exclude subjects who meet any of the following criteria: (1) Diseases accompanied by pharyngeal conjunctivitis, acute exacerbation of chronic bronchitis, purulent tonsillitis, and infectious upper respiratory tract infection; (2) People with uncontrolled cardiovascular and cerebrovascular diseases, diabetes, hypertension, thyroid disease, asthma, glaucoma, emphysema, chronic lung diseases, breathing difficulties or prostatic hypertrophy; (3) Patients with pneumonia confirmed by chest imaging; (4) Those who have used drugs to treat the disease after the onset of illness; (5) Those who are currently taking nourishing proprietary Chinese medicines or monoamine oxidase inhibitors; (6) Aspartate aminotransferase (AST) or alanine aminotransferase (ALT)> 3 times the upper limit of normal value or active liver disease; (7) Serum creatinine> 2 times the upper limit of normal or undergoing renal dialysis treatment; (8) Axillary temperature >= 40 degrees C, total number of white blood cells>10x109/L or neutrophil classification>80%; (9) Those who are allergic to the drugs used in this research; (10) Mental and neurological disorders, who cannot express their wishes correctly; (11) Pregnant women, lactating women and women of childbearing age who have not taken contraceptive measures; (12) Those who are currently participating in clinical trials of other drugs or medical devices; (13) The investigator believes that it is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery rate on the 3rd day of treatment; | — |
Countries
China